Principia BioPharma principiabio.com


Public list: BIO 2016 (619) Pharma Startups (4732) Cancer Therapeutics (1137)

Principia Biopharma is a biopharmaceutical company focused on discovering and developing small molecule drugs within the fields of autoimmune disease and oncology that are potent, safe and have antibody-like specificity for their targets. Expanding on technology originally licensed from the University of California, San Francisco, the company has built a drug discovery and development engine broadly utilizing its technology around reversible covalent small molecule inhibitors. This tailored cova...Show all

Principia Biopharma is a biopharmaceutical company focused on discovering and developing small molecule drugs within the fields of autoimmune disease and oncology that are potent, safe and have antibody-like specificity for their targets. Expanding o...Show all

Company (IPO / Went public)

Phone: 650-416-7700

Fax:

400 East Jamie Court
Suite 302
South San Francisco, 94080
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Principia BioPharma $246.2M Sep 14, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Principia BioPharma Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Benzimidazole derivatives as rlk and itk inhibitors Feb 23, 2015 Apr 03, 2018 Patent
Quinolone derivatives as fibroblast growth factor receptor inhibitors Feb 04, 2015 Nov 14, 2017 Patent
Tyrosine kinase inhibitors Jan 19, 2017 Jun 27, 2017 Patent
Substituted pyrrolo[2,3-b]pyrazines as jak3 inhibitors Nov 19, 2013 Jun 13, 2017 Patent
Quinolone derivatives as fibroblast growth factor inhibitors May 07, 2014 Apr 25, 2017 Patent
See all 28 patents